Renaud A. Du Pasquier, M.D. is professor of Neurology, Chairman of the Division of  neurology and Head of the Laboratory of Neuroimmunology at the University Hospital of  Vaud (CHUV), University of Lausanne, Switzerland. He performed his medical studies and was board-certified in Internal Medicine and Neurology in Geneva, Switzerland.  

From 1999 to 2004, he did a post-doc in neuroimmunology and neurovirology at the Beth  Israel Deaconess Medical Center, Harvard Medical School in Boston in Norman Letvin and  Igor Koralnik’s laboratory.  

Primarily devoted to the research in Multiple Sclerosis (MS), his laboratory has studied in  detail the involvement of Epstein-Barr virus (EBV) in the pathogenesis of MS, using EBV specific CD8+ T cells as a signature. His team has now embarked into an ambitious project,  trying to decipher the interaction of CD8+ T cells and auto-reactive antibodies with  autologous CNS cells, using human induced pluripotent stem cells.  

His laboratory also studies the interaction between the new disease modifying therapies for  MS and the antiviral responses, mostly to JC virus, the agent of progressive multifocal  leukoencephalopathy (PML). Finally, he holds a clinical research program dealing with the  neurocognitive disorders in HIV+ patients.